Fig. 1From: Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: a patient preference studyStudy design. AE = adverse event; DE = direct elicitation; HCC = hepatocellular carcinoma; IV = intravenous; TT = threshold techniqueBack to article page